Relay Therapeutics, Inc. (RLAY)
7.80
-0.19
(-2.38%)
USD |
NASDAQ |
Jan 12, 16:00
7.795
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics EPS Diluted (Quarterly): -0.4301 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Theravance Biopharma, Inc. | 0.0696 |
| Prelude Therapeutics, Inc. | -0.2591 |
| Immunome, Inc. | -0.6532 |
| ImmunityBio, Inc. | -0.071 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.15M |
| Total Expenses (Quarterly) | 74.15M |
| Enterprise Value | 788.81M |
| Earnings Yield | -22.44% |
| Normalized Earnings Yield | -22.44 |